QL
NRIX icon

Quarry LP’s Nurix Therapeutics NRIX Stock Holding History

Quarry LP’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121 Buy
+5
New +$85 ﹤0.01% 2333
2024
Q4 		– Sell
-2,500
Closed -$56.2K – 1894
2024
Q3 		$56.2K Buy
2,500
+2,435
+3,746% +$55.2K 0.01% 672
2024
Q2 		$1.36K Buy
+65
New +$1.01K ﹤0.01% 1670

Other funds holding NRIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Quarry LP's NRIX Position: Q2 2026 in Review

Quarry LP opened a new position in Nurix Therapeutics (NRIX) in Q2 2026: 5 shares worth $121. The stake represents ﹤0.01% of the portfolio and ranks #2333 among its holdings. This is a return to the name: Quarry LP previously reported a position in NRIX as recently as Q3 2024.

Quarry LP first reported a position in NRIX in Q2 2024 and has held it in 3 quarters since. The position peaked at $56.2K in Q3 2024. 212 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

  • Quarry LP held 5 shares of Nurix Therapeutics worth $121 as of Q2 2026.
  • Nurix Therapeutics was a new Quarry LP position in Q2 2026.
  • Nurix Therapeutics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #2333 holding.
  • Quarry LP first reported a position in Nurix Therapeutics in Q2 2024 and has held it in 3 quarters since.
  • Quarry LP's Nurix Therapeutics position peaked at $56.2K in Q3 2024.
  • 212 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.